Sierra-Pagan Javier E, Garry Daniel J
Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
Stem Cell Institute, University of Minnesota, Minneapolis, MN, United States.
Front Cardiovasc Med. 2022 Aug 23;9:972591. doi: 10.3389/fcvm.2022.972591. eCollection 2022.
Cardiovascular disease (CVD) remains the number one cause of death worldwide. Ischemic heart disease contributes to heart failure and has considerable morbidity and mortality. Therefore, alternative therapeutic strategies are urgently needed. One class of epigenetic regulators known as pioneer factors has emerged as an important tool for the development of regenerative therapies for the treatment of CVD. Pioneer factors bind closed chromatin and remodel it to drive lineage specification. Here, we review pioneer factors within the cardiovascular lineage, particularly during development and reprogramming and highlight the implications this field of research has for the future development of cardiac specific regenerative therapies.
心血管疾病(CVD)仍然是全球头号死因。缺血性心脏病会导致心力衰竭,且发病率和死亡率相当高。因此,迫切需要替代治疗策略。一类被称为先驱因子的表观遗传调节因子已成为开发用于治疗CVD的再生疗法的重要工具。先驱因子与封闭的染色质结合并对其进行重塑,以驱动细胞谱系特化。在这里,我们综述心血管谱系中的先驱因子,特别是在发育和重编程过程中的情况,并强调这一研究领域对心脏特异性再生疗法未来发展的意义。